Akari Therapeutics Plc (AKTX)

0.2806 +0.01 (+4.98%) USD  |  NASDAQ  |  Jan 16, 16:00
0.28 0.00 (0.00%) After-Hours: 20:00
More

Akari Therapeutics Current Deferred Revenue (Per Share)

Current Deferred Revenue (Per Share) Chart

View Current Deferred Revenue (Per Share) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Revenue (Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Revenue (Per Share) Range, Past 5 Years

View Current Deferred Revenue (Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Revenue (Per Share) Benchmarks

View Current Deferred Revenue (Per Share) Benchmarks
Start Trial
DBV Technologies SA --
Cellectis SA Upgrade
Biodexa Pharmaceuticals Plc Upgrade
NuCana Plc --
Autolus Therapeutics Plc Upgrade